Harvard Bioscience (HBIO) Revenue Growth (5y) (2015 - 2026)
Harvard Bioscience (HBIO) Revenue Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 126.58 Bn | 121.36 Bn | 1.96 Bn |
| 2 | Becton Dickinson | 44.90 Bn | 44.08 Bn | 2.15 Bn |
| 3 | Alcon | 32.95 Bn | 31.29 Bn | 1.53 Bn |
| 4 | Medline | 32.83 Bn | 30.59 Bn | 1.84 Bn |
| 5 | Resmed | 29.38 Bn | 27.72 Bn | 890.98 Mn |
| 6 | West Pharmaceutical Services | 23.41 Bn | 22.98 Bn | 329.20 Mn |
| 7 | Solventum | 14.08 Bn | 13.52 Bn | 1.10 Bn |
| 8 | Cooper Companies | 13.79 Bn | 13.66 Bn | 735.40 Mn |
| 9 | Align Technology | 12.03 Bn | 10.97 Bn | 736.59 Mn |
| 10 | Harvard Bioscience | 27.26 Mn | 20.16 Mn | 12.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5.12% |
| Dec 31, 2025 | -5.19% |
| Sep 30, 2025 | -3.05% |
| Jun 30, 2025 | -2.58% |
| Mar 31, 2025 | -1.74% |
| Dec 31, 2024 | -4.54% |
| Sep 30, 2024 | -4.33% |
| Jun 30, 2024 | -4.83% |
| Mar 31, 2024 | -2.77% |
| Dec 31, 2023 | -3.62% |
| Sep 30, 2023 | -2.40% |
| Jun 30, 2023 | -1.82% |
| Mar 31, 2023 | 2.30% |
| Dec 31, 2022 | 5.60% |
| Sep 30, 2022 | 7.54% |
| Jun 30, 2022 | 9.03% |
| Mar 31, 2022 | 9.73% |
| Dec 31, 2021 | 4.59% |
| Sep 30, 2021 | 3.47% |
| Jun 30, 2021 | 2.24% |